DEVICE · Unmapped registry intervention
Greater Splanchnic Nerve Ablation
Find medicine records ·
Find other trials using this name
Clinical trial
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
NCT04592445
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DEVICE · Unmapped registry intervention
Sham Control
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEndovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sham ControlDEVICE
Sponsors & collaborators
Axon Therapies, Inc.lead sponsor
NAMSAcollaborator
Cardiovascular Research Foundation, New Yorkcollaborator
Northwestern Universitycollaborator
Mapped research locations
New YorkNew York, United States3ChicagoIllinois, United States2San FranciscoCalifornia, United States2HoustonTexas, United States1St LouisMissouri, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1Ann ArborMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04592445 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.